Indian FDA pushes for broader generic-drug use

04/21/2013 | Times of India, The

A state Food and Drug Administration commissioner in India denied that the bio-availability of generic drugs is doubtful, in spite of claims to the contrary made by doctors and chemists. "Bio-availability" is a term used for the amount of a drug that reaches its target. "These are excuses to deny people their right to get medicines at rational prices," said Commissioner Mahesh Zagade, who urged the national government to require that physicians add a line to prescriptions noting that generic or other cheaper versions are available.

View Full Article in:

Times of India, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN